Alzheimer's disease

News - Alzheimer's disease

Amyvid(TM) (Florbetapir F 18 Injection) Now Available in Select U.S. Markets

2012-06-01 06:23:08

INDIANAPOLIS, June 1, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced that Amyvid

Avanir Pharmaceuticals Announces Three Poster Presentations at Consortium of MS Centers Meeting Including Preliminary Results From PRISM Patient Registry

2012-06-01 02:25:02

ALISO VIEJO, Calif., June 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc.

Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)

2012-06-01 02:24:51

DUBLIN, Ohio, June 1, 2012 /PRNewswire/ -- Cardinal Health today announced that it will manufacture and distribute Amyvid, Eli Lilly and Company's new diagnostic imaging agent that aids in

Alzheimer's Foundation of America and Senior Helpers Collaborate to Expand Education and Resources in Local Communities

2012-05-31 06:28:57

AFA Affiliate Offices Respond to Needs of Increasing Dementia Population NEW YORK, May 31, 2012 /PRNewswire-USNewswire/ -- As the need for education and resources

How The World's First Drug For Amyloid Disease Works

2012-05-30 10:03:52

Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel®) works.

More News (5646 articles) »